Research Article | | Peer-Reviewed

Neurovascular Coupling in Neurological Disorders: A Comprehensive Review

Received: 11 October 2025     Accepted: 29 October 2025     Published: 26 November 2025
Views:       Downloads:
Abstract

This article provides a systematic review of current research on Neurovascular Coupling (NVC), covering its fundamental mechanisms, role in diseases, investigative technologies, and future directions. NVC describes the process where neuronal activity triggers localized changes in cerebral blood flow (CBF). This mechanism is orchestrated by the Neurovascular Unit (NVU), a functional complex comprising neurons, glial cells (e.g., astrocytes), and vascular cells (e.g., endothelial cells, pericytes, vascular smooth muscle cells). These components work in concert through intercellular signaling to co-regulate CBF. The regulation involves various vasoactive substances, including nitric oxide (NO) and prostaglandin E2 (PGE2).Dysfunction of NVC is a critical pathological mechanism in neurological disorders. In Alzheimer's disease, abnormalities across the NVU lead to blood-brain barrier disruption and impaired clearance of amyloid-β, exacerbating cognitive decline. Similarly, in cerebral small vessel disease, endothelial dysfunction manifesting as impaired NVC is a key feature, with severity correlating with structural damage like white matter hyperintensities. Following an ischemic stroke, NVU component abnormalities cause acute NVC decoupling, and the degree of functional recovery is closely associated with neurological prognosis. Technologies for studying NVC are evolving. Established methods include functional Magnetic Resonance Imaging (fMRI), which measures the blood-oxygen-level-dependent (BOLD) signal, and transcranial Doppler ultrasound. Recent advancements feature novel tools like high-speed, large-field-of-view photoacoustic/fluorescence hybrid microscopes (e.g., LiTA-HM), enabling cortex-wide imaging of neurovascular dynamics with subcellular resolution. Current research challenges include reliance on animal models. Future directions should integrate structural and functional neuroimaging techniques. Therapeutically, strategies aimed at enhancing endothelial function to restore NVC hold promise. Combining advanced imaging with omics technologies will likely deepen the understanding of the NVU and propel the field toward precise prevention and treatment of NVC-related diseases.

Published in Clinical Neurology and Neuroscience (Volume 9, Issue 4)
DOI 10.11648/j.cnn.20250904.11
Page(s) 52-61
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2025. Published by Science Publishing Group

Keywords

Neurovascular Coupling, Neurovascular Unit, Alzheimer's Disease, Parkinson's Disease, Hypertension, Stroke

References
[1] Novak V, Hajjar I. The relationship between blood pressure and cognitive function [J]. Nature Reviews Cardiology, 2010, 7(12): 686-698.
[2] Drew P J. Neurovascular coupling: motive unknown [J]. Trends in neurosciences, 2022, 45(11): 809-819.
[3] Liu L, Liu J, Bao J, et al. Interaction of microglia and astrocytes in the neurovascular unit [J]. Frontiers in immunology, 2020, 11: 1024.
[4] Grubb S, Lauritzen M, Aalkjær C. Brain capillary pericytes and neurovascular coupling [J]. Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, 2021, 254: 110893.
[5] Martineau É, Malescot A, Elmkinssi N, et al. Distal activity patterns shape the spatial specificity of neurovascular coupling [J]. Nature Neuroscience, 2024, 27(11): 2101-2114.
[6] Tiedt S, Buchan A M, Dichgans M, et al. The neurovascular unit and systemic biology in stroke—implications for translation and treatment [J]. Nature Reviews Neurology, 2022, 18(10): 597-612.
[7] Li T, Wang L, Piao Z, et al. Altered neurovascular coupling for multidisciplinary intensive rehabilitation in Parkinson's disease [J]. Journal of Neuroscience, 2023, 43(7): 1256-1266.
[8] Magyar-Sumegi Z D, Csendes M, Lendvai-Emmert D, et al. Chronic impairment of neurovascular coupling and cognitive decline in young survivors of severe traumatic brain injury [J]. GeroScience, 2025: 1-13.
[9] Meng L, Rasmussen M, Meng D M, et al. Integrated feedforward and feedback mechanisms in neurovascular coupling [J]. Anesthesia & Analgesia, 2024, 139(6): 1283-1293.
[10] Hosford P S, Gourine A V. What is the key mediator of the neurovascular coupling response? [J]. Neuroscience & Biobehavioral Reviews, 2019, 96: 174-181.
[11] Roy R K, Althammer F, Seymour A J, et al. Inverse neurovascular coupling contributes to positive feedback excitation of vasopressin neurons during a systemic homeostatic challenge [J]. Cell reports, 2021, 37(5).
[12] Attwell D, Buchan A M, Charpak S, et al. Glial and neuronal control of brain blood flow [J]. Nature, 2010, 468(7321): 232-243.
[13] Vermeulen T D, Benbaruj J, Brown C V, et al. Acute intermittent hypercapnic hypoxia and cerebral neurovascular coupling in males and females [J]. Experimental Neurology, 2020, 334: 113441.
[14] Du C, Park K, Hua Y, et al. Astrocytes modulate cerebral blood flow and neuronal response to cocaine in prefrontal cortex [J]. Molecular psychiatry, 2024, 29(3): 820-834.
[15] Institoris A, Vandal M, Peringod G, et al. Astrocytes amplify neurovascular coupling to sustained activation of neocortex in awake mice [J]. Nature communications, 2022, 13(1): 7872.
[16] Császár E, Lénárt N, Cserép C, et al. Microglia modulate blood flow, neurovascular coupling, and hypoperfusion via purinergic actions [J]. Journal of Experimental Medicine, 2022, 219(3): e20211071.
[17] Alarcon-Martinez L, Villafranca-Baughman D, Quintero H, et al. Interpericyte tunnelling nanotubes regulate neurovascular coupling [J]. Nature, 2020, 585(7823): 91-95.
[18] Meza-Resillas J, O'Hara F, Kaushik S, et al. Systemic nimodipine affects pericyte calcium signaling, resting hemodynamics and neurovascular coupling in healthy mouse brain [J]. Neurotherapeutics, 2025: e00614.
[19] Divecha Y A, Rampes S, Tromp S, et al. The microcirculation, the blood-brain barrier and the neurovascular unit in health and Alzheimer’s Disease. The aberrant pericyte is a central player [J]. Pharmacological Reviews, 2025: 100052.
[20] Zhu W M, Neuhaus A, Beard D J, et al. Neurovascular coupling mechanisms in health and neurovascular uncoupling in Alzheimer’s disease [J]. Brain, 2022, 145(7): 2276-2292.
[21] Zimmer A R, Bourourou M, Lesage F, et al. Neurovascular coupling and functional connectivity changes through the Alzheimer's disease spectrum: Effects of simvastatin treatment [J]. Alzheimer's & Dementia, 2025, 21(8): e70402.
[22] Kisler K, Nelson A R, Montagne A, et al. Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease [J]. Nature Reviews Neuroscience, 2017, 18(7): 419-434.
[23] Shang J, Yamashita T, Zhai Y, et al. Strong Impact of Chronic Cerebral Hypoperfusion on Neurovascular Unit, Cerebrovascular Remodeling, and Neurovascular Trophic Coupling in Alzheimer’s Disease Model Mouse [J]. Journal of Alzheimer’s Disease, 2016, 52(1): 113-26.
[24] Nelson A R. Peripheral pathways to neurovascular unit dysfunction, cognitive impairment, and Alzheimer’s disease [J]. Frontiers in aging neuroscience, 2022, 14: 858429.
[25] Huang W, Xia Q, Zheng F, et al. Microglia-mediated neurovascular unit dysfunction in Alzheimer’s disease [J]. Journal of Alzheimer’s Disease, 2023, 94(s1): S335-S354.
[26] Csiszar A, Tarantini S, Fülöp G A, et al. Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer’s disease [J]. Geroscience, 2017, 39(4): 359-372.
[27] Liu X, Hou D R, Lin F B, et al. The role of neurovascular unit damage in the occurrence and development of Alzheimer’s disease [J]. Reviews in the Neurosciences, 2019, 30(5): 477-484.
[28] Zhao T, Pan P, Jia Y, et al. Crossing Pathological Boundaries: Multi-Target Restoration of the Neurovascular Unit in Alzheimer's and Vascular Dementia-From Modern Therapeutics to Traditional Chinese Medicine [J]. Aging and disease.
[29] Alshibani A A K. Parkinson's Disease: An Integrative Analysis of Pathophysiology, Genetic Susceptibility, Diagnosis, Therapeutic Strategies, and Emerging Researches [J]. Bani Waleed University Journal of Humanities and Applied Sciences, 2025, 10(2): 520-536.
[30] De Lau L M L, Breteler M M B. Epidemiology of Parkinson's disease [J]. The Lancet Neurology, 2006, 5(6): 525-535.
[31] Miyazaki I, Asanuma M. Neuron-astrocyte interactions in Parkinson’s disease [J]. Cells, 2020, 9(12): 2623.
[32] Si X, Dai S, Fang Y, et al. Matrix metalloproteinase-9 inhibition prevents aquaporin-4 depolarization-mediated glymphatic dysfunction in Parkinson’s disease [J]. Journal of advanced research, 2024, 56: 125-136.
[33] Morrone Parfitt G, Coccia E, Goldman C, et al. Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson’s disease model [J]. Nature Communications, 2024, 15(1): 447.
[34] Shang S, Ye J, Wu J, et al. Early disturbance of dynamic synchronization and neurovascular coupling in cognitively normal Parkinson’s disease [J]. Journal of Cerebral Blood Flow & Metabolism, 2022, 42(9): 1719-1731.
[35] Lau K, Kotzur R, Richter F. Blood–brain barrier alterations and their impact on Parkinson’s disease pathogenesis and therapy [J]. Translational neurodegeneration, 2024, 13(1): 37.
[36] Wang T, Sun Y, Dettmer U. Astrocytes in Parkinson’s disease: from role to possible intervention [J]. Cells, 2023, 12(19): 2336.
[37] Zhu H, Xiao F, Xiao Y, et al. Targeting CB2R in astrocytes for Parkinson's disease therapy: unraveling the Foxg1-mediated neuroprotective mechanism through autophagy-mediated NLRP3 degradation [J]. Journal of Neuroinflammation, 2023, 20(1): 304.
[38] Garcia R, Zarate S, Srinivasan R. [J]. Astrocyte-Neuron Interactions in Health and Disease. The role of astrocytes in parkinson’s disease: astrocytes in parkinson’s disease, 2024: 319-343.
[39] Jiang S Y, Tian T, Yao H, et al. The cGAS-STING-YY1 axis accelerates progression of neurodegeneration in a mouse model of Parkinson’s disease via LCN2-dependent astrocyte senescence [J]. Cell Death & Differentiation, 2023, 30(10): 2280-2292.
[40] Kam T I, Hinkle J T, Dawson T M, et al. Microglia and astrocyte dysfunction in parkinson's disease [J]. Neurobiology of disease, 2020, 144: 105028.
[41] de Montgolfier O, Thorin-Trescases N, Thorin E. Pathological continuum from the rise in pulse pressure to impaired neurovascular coupling and cognitive decline [J]. American journal of hypertension, 2020, 33(5): 375-390.
[42] Dunn K M, Nelson M T. Neurovascular signaling in the brain and the pathological consequences of hypertension [J]. American Journal of Physiology-Heart and Circulatory Physiology, 2014, 306(1): H1-H14.
[43] Iadecola C, Gottesman R F. Neurovascular and cognitive dysfunction in hypertension: epidemiology, pathobiology, and treatment [J]. Circulation research, 2019, 124(7): 1025-1044.
[44] Monteiro A, Castro P, Pereira G, et al. Cerebral blood flow regulation and cognitive performance in hypertension [J]. Journal of Cerebral Blood Flow & Metabolism, 2024, 44(11): 1277-1287.
[45] Wu H, Sun Q, Yuan S, et al. AT1 receptors: their actions from hypertension to cognitive impairment [J]. Cardiovascular Toxicology, 2022, 22(4): 311-325.
[46] Presa J L, Saravia F, Bagi Z, et al. Vasculo-neuronal coupling and neurovascular coupling at the neurovascular unit: impact of hypertension [J]. Frontiers in physiology, 2020, 11: 584135.
[47] Stamatovic S M, Phillips C M, Martinez-Revollar G, et al. Involvement of epigenetic mechanisms and non-coding RNAs in blood-brain barrier and neurovascular unit injury and recovery after stroke [J]. Frontiers in neuroscience, 2019, 13: 864.
[48] Steliga A, Kowiański P, Czuba E, et al. Neurovascular unit as a source of ischemic stroke biomarkers—limitations of experimental studies and perspectives for clinical application [J]. Translational stroke research, 2020, 11(4): 553-579.
[49] Li Z, McConnell H L, Stackhouse T L, et al. Increased 20-HETE signaling suppresses capillary neurovascular coupling after ischemic stroke in regions beyond the infarct [J]. Frontiers in Cellular Neuroscience, 2021, 15: 762843.
[50] Su E J, Fredriksson L, Schielke G P, et al. Tissue plasminogen activator-mediated PDGF signaling and neurovascular coupling in stroke [J]. Journal of Thrombosis and Haemostasis, 2009, 7: 155-158.
[51] Sun J, Chi L, He Z, et al. NLRP3 inflammasome contributes to neurovascular unit damage in stroke [J]. Journal of drug targeting, 2019, 27(8): 866-875.
[52] Wang L, Xiong X, Zhang L, et al. Neurovascular unit: a critical role in ischemic stroke [J]. CNS Neuroscience & Therapeutics, 2021, 27(1): 7-16.
[53] Wierońska J M, Cieślik P, Kalinowski L. Nitric oxide-dependent pathways as critical factors in the consequences and recovery after brain ischemic hypoxia [J]. Biomolecules, 2021, 11(8): 1097.
[54] Qin C, Yang S, Chu Y H, et al. Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions [J]. Signal transduction and targeted therapy, 2022, 7(1): 215.
[55] Chamorro Á, Dirnagl U, Urra X, et al. Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation [J]. The Lancet Neurology, 2016, 15(8): 869-881.
[56] Gao X, Liu D, Yue K, et al. Revolutionizing ischemic stroke diagnosis and treatment: the promising role of neurovascular unit-derived extracellular vesicles [J]. Biomolecules, 2024, 14(3): 378.
[57] Logothetis N K, Pauls J, Augath M, et al. Neurophysiological investigation of the basis of the fMRI signal [J]. nature, 2001, 412(6843): 150-157.
[58] Burma J S, Bailey D M, Johnson N E, et al. Physiological influences on neurovascular coupling: A systematic review of multimodal imaging approaches and recommendations for future study designs [J]. Experimental Physiology, 2025, 110(1): 23-41.
[59] Shahsavarani S, Thibodeaux D N, Xu W, et al. Cortex-wide neural dynamics predict behavioral states and provide a neural basis for resting-state dynamic functional connectivity [J]. Cell reports, 2023, 42(6).
[60] Liu L, Xu Z, Lai Z, et al. Photoacoustic and fluorescence hybrid microscope for cortex-wide imaging of neurovascular dynamics with subcellular resolution [J]. Science Advances, 2025, 11(30): eadw5275.
[61] Wan X, Yin X, Chai X, et al. Evaluation of neurovascular coupling in early-onset and late-onset epilepsy of unknown etiology [J]. Journal of Magnetic Resonance Imaging, 2025, 61(6): 2489-2500.
[62] Ball J D, Hills E, Altaf A, et al. Neurovascular coupling methods in healthy individuals using transcranial doppler ultrasonography: A systematic review and consensus agreement [J]. Journal of Cerebral Blood Flow & Metabolism, 2024, 44(12): 1409-1429.
[63] Senée P, Krafft L, Loukili I, et al. Revealing neurovascular coupling at a high spatial and temporal resolution in the living human retina [J]. Science Advances, 2025, 11(26): eadx2941.
[64] Chen N, Xu Z, Song Z, et al. Simultaneous head-mounted imaging of neural and hemodynamic activities at high spatiotemporal resolution in freely behaving mice [J]. Science Advances, 2025, 11(12): eadu1153.
[65] Chen Y, Qian W, Razansky D, et al. WISDEM: a hybrid wireless integrated sensing detector for simultaneous EEG and MRI [J]. Nature Methods, 2025: 1-10.
[66] Burma J S, Oni I K, Lapointe A P, et al. Quantifying neurovascular coupling through a concurrent assessment of arterial, capillary, and neuronal activation in humans: A multimodal EEG-fNIRS-TCD investigation [J]. Neuroimage, 2024, 302: 120910.
Cite This Article
  • APA Style

    Ye, Z., Wang, Y., Zhang, Q. (2025). Neurovascular Coupling in Neurological Disorders: A Comprehensive Review. Clinical Neurology and Neuroscience, 9(4), 52-61. https://doi.org/10.11648/j.cnn.20250904.11

    Copy | Download

    ACS Style

    Ye, Z.; Wang, Y.; Zhang, Q. Neurovascular Coupling in Neurological Disorders: A Comprehensive Review. Clin. Neurol. Neurosci. 2025, 9(4), 52-61. doi: 10.11648/j.cnn.20250904.11

    Copy | Download

    AMA Style

    Ye Z, Wang Y, Zhang Q. Neurovascular Coupling in Neurological Disorders: A Comprehensive Review. Clin Neurol Neurosci. 2025;9(4):52-61. doi: 10.11648/j.cnn.20250904.11

    Copy | Download

  • @article{10.11648/j.cnn.20250904.11,
      author = {Zi Ye and Yixiao Wang and Qi Zhang},
      title = {Neurovascular Coupling in Neurological Disorders: A Comprehensive Review
    },
      journal = {Clinical Neurology and Neuroscience},
      volume = {9},
      number = {4},
      pages = {52-61},
      doi = {10.11648/j.cnn.20250904.11},
      url = {https://doi.org/10.11648/j.cnn.20250904.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cnn.20250904.11},
      abstract = {This article provides a systematic review of current research on Neurovascular Coupling (NVC), covering its fundamental mechanisms, role in diseases, investigative technologies, and future directions. NVC describes the process where neuronal activity triggers localized changes in cerebral blood flow (CBF). This mechanism is orchestrated by the Neurovascular Unit (NVU), a functional complex comprising neurons, glial cells (e.g., astrocytes), and vascular cells (e.g., endothelial cells, pericytes, vascular smooth muscle cells). These components work in concert through intercellular signaling to co-regulate CBF. The regulation involves various vasoactive substances, including nitric oxide (NO) and prostaglandin E2 (PGE2).Dysfunction of NVC is a critical pathological mechanism in neurological disorders. In Alzheimer's disease, abnormalities across the NVU lead to blood-brain barrier disruption and impaired clearance of amyloid-β, exacerbating cognitive decline. Similarly, in cerebral small vessel disease, endothelial dysfunction manifesting as impaired NVC is a key feature, with severity correlating with structural damage like white matter hyperintensities. Following an ischemic stroke, NVU component abnormalities cause acute NVC decoupling, and the degree of functional recovery is closely associated with neurological prognosis. Technologies for studying NVC are evolving. Established methods include functional Magnetic Resonance Imaging (fMRI), which measures the blood-oxygen-level-dependent (BOLD) signal, and transcranial Doppler ultrasound. Recent advancements feature novel tools like high-speed, large-field-of-view photoacoustic/fluorescence hybrid microscopes (e.g., LiTA-HM), enabling cortex-wide imaging of neurovascular dynamics with subcellular resolution. Current research challenges include reliance on animal models. Future directions should integrate structural and functional neuroimaging techniques. Therapeutically, strategies aimed at enhancing endothelial function to restore NVC hold promise. Combining advanced imaging with omics technologies will likely deepen the understanding of the NVU and propel the field toward precise prevention and treatment of NVC-related diseases.
    },
     year = {2025}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Neurovascular Coupling in Neurological Disorders: A Comprehensive Review
    
    AU  - Zi Ye
    AU  - Yixiao Wang
    AU  - Qi Zhang
    Y1  - 2025/11/26
    PY  - 2025
    N1  - https://doi.org/10.11648/j.cnn.20250904.11
    DO  - 10.11648/j.cnn.20250904.11
    T2  - Clinical Neurology and Neuroscience
    JF  - Clinical Neurology and Neuroscience
    JO  - Clinical Neurology and Neuroscience
    SP  - 52
    EP  - 61
    PB  - Science Publishing Group
    SN  - 2578-8930
    UR  - https://doi.org/10.11648/j.cnn.20250904.11
    AB  - This article provides a systematic review of current research on Neurovascular Coupling (NVC), covering its fundamental mechanisms, role in diseases, investigative technologies, and future directions. NVC describes the process where neuronal activity triggers localized changes in cerebral blood flow (CBF). This mechanism is orchestrated by the Neurovascular Unit (NVU), a functional complex comprising neurons, glial cells (e.g., astrocytes), and vascular cells (e.g., endothelial cells, pericytes, vascular smooth muscle cells). These components work in concert through intercellular signaling to co-regulate CBF. The regulation involves various vasoactive substances, including nitric oxide (NO) and prostaglandin E2 (PGE2).Dysfunction of NVC is a critical pathological mechanism in neurological disorders. In Alzheimer's disease, abnormalities across the NVU lead to blood-brain barrier disruption and impaired clearance of amyloid-β, exacerbating cognitive decline. Similarly, in cerebral small vessel disease, endothelial dysfunction manifesting as impaired NVC is a key feature, with severity correlating with structural damage like white matter hyperintensities. Following an ischemic stroke, NVU component abnormalities cause acute NVC decoupling, and the degree of functional recovery is closely associated with neurological prognosis. Technologies for studying NVC are evolving. Established methods include functional Magnetic Resonance Imaging (fMRI), which measures the blood-oxygen-level-dependent (BOLD) signal, and transcranial Doppler ultrasound. Recent advancements feature novel tools like high-speed, large-field-of-view photoacoustic/fluorescence hybrid microscopes (e.g., LiTA-HM), enabling cortex-wide imaging of neurovascular dynamics with subcellular resolution. Current research challenges include reliance on animal models. Future directions should integrate structural and functional neuroimaging techniques. Therapeutically, strategies aimed at enhancing endothelial function to restore NVC hold promise. Combining advanced imaging with omics technologies will likely deepen the understanding of the NVU and propel the field toward precise prevention and treatment of NVC-related diseases.
    
    VL  - 9
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • Sections